Resmed Inc Share Price and Company Fundamentals
Last traded: Today at 3:15 AM
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
|Primary activities||Medical device manufacturing|
|Industry / Sector||Medical Instruments & Supplies / Healthcare|
|Full time employees||7770|
|Mailing address||9001 Spectrum Center Boulevard San Diego CA 92123 United States|
|Phone / Fax||858 836 5000 /|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
Resmed Inc paid $1.56 dividend and the ex-dividend date was 12 May 2021.The dividend payout ratio is 37.38%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.RMD dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
RMD's forward dividend amount is $0.2 and the forward dividend yield is 0.63%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of Aug 2021, following are the company executives and directors listed on Resmed Inc.
|Dr. Peter C. Farrell A.M., B.E., Ph.D., BE (Hons), ScD, AM||Founder & Non-Exec. Chairman||78||431.8k|
|Mr. Michael J. Farrell BE, SM, MBA||CEO & Director||48||2.73M|
|Mr. Robert A. Douglas||Pres & COO||60||1.99M|
|Mr. Brett A. Sandercock||Chief Financial Officer||53||907.65k|
|Dr. James R. Hollingshead Ph.D.||Pres of Sleep & Respiratory Care Bus.||57||1.27M|
|Mr. Rajwant Singh Sodhi||Pres of Software as a Service Bus. (SaaS)||47||1.04M|
|Mr. Kaushik Ghoshal||Chief Technology Officer|
|Mr. David B. Pendarvis||Chief Admin. Officer, Global Gen. Counsel & Corp. Sec.||61|
|Ms. Constance C. Bienfait||Director of Investor Relations|
|Ms. Amy Wakeham||VP of Investor Relations & Corp. Communications|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Resmed Inc is 53.26B and its enterprise value is 19.51B. The enterprise value to revenue ratio of RMD is 6.31.
The RMD's stocks Beta value is 0.28 making it 72% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Resmed Inc (RMD)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Sonic Healthcare (SHL)
Resmed Inc (ASX:RMD) Frequently Asked Questions
1. What is Resmed Inc's Stock Symbol?
Resmed Inc trades on ASX under the ticker symbol "RMD".
2. What is Resmed Inc's stock price today?
One share of RMD stock can currently be purchased for approximately $36.69.
3. How can I contact Resmed Inc?
Resmed Inc's mailing address is 9001 Spectrum Center Boulevard San Diego CA 92123 United States. The company can be reached via phone at 858 836 5000.
4. What is Resmed Inc's official website?
The official website of Resmed Inc is http://www.resmed.com.
5. Which share registry manages Resmed Inc's stock?
Resmed Inc's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.